During the past decade, Preferred Primary Care Physicians, Inc. conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 31 clinical trials were completed, i.e. on average, 68.9% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 23 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Preferred Primary Care Physicians, Inc." #1 sponsor was "Pfizer" with 14 trials, followed by "Allergan" with 9 trials sponsored, "Eli Lilly and Company" with 7 trials sponsored, "Amgen" with 3 trials sponsored and "Forest Laboratories" with 3 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Preferred Primary Care Physicians, Inc." #1 collaborator was "Ironwood Pharmaceuticals, Inc." with 3 trials as a collaborator, "PPD" with 3 trials as a collaborator, "Novartis" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "Clinvest Research, LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Preferred Primary Care Physicians, Inc." are "Migraine" (10 trials), "Diabetes Mellitus" (4 trials), "Gastroparesis" (4 trials), "Diabetes Mellitus, Type 2" (3 trials) and "Episodic Migraine" (3 trials). Many other conditions were trialed in "Preferred Primary Care Physicians, Inc." in a lesser frequency.

Most popular intervention types in "Preferred Primary Care Physicians, Inc." are "Drug" (45 trials), "Biological" (8 trials), "Other" (6 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (31 trials), "Dulaglutide" (3 trials), "Relamorelin" (3 trials), "Tirzepatide" (3 trials) and "ABP-450" (2 trials). Other intervention names were less common.

The vast majority of trials in "Preferred Primary Care Physicians, Inc." are 54 trials for "All" genders.

Currently, there are NaN active trials in "Preferred Primary Care Physicians, Inc.". undefined are not yet recruiting, 11 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 26 completed trials in Preferred Primary Care Physicians, Inc., undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Preferred Primary Care Physicians, Inc., 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 1 trials that are defined as “Not Applicable".